Novel approaches for the treatment of infections due to multidrug-resistant bacterial pathogens.

Imran, Mohmmad; Ahmad, Mohammad Naiyaz; Dasgupta, Arunava; Rana, Preeti; Srinivas, Nanduri; Chopra, Sidharth

Imran, Mohmmad; Ahmad, Mohammad Naiyaz; Dasgupta, Arunava; Rana, Preeti; Srinivas, Nanduri; Chopra, Sidharth.

Afiliação

Imran M; Division of Microbiology, CSIR-Central Drug Research Institute, Sector 10, Janakipuram Extension, Sitapur Road, Lucknow, 226031, India.
Ahmad MN; Academy of Scientific & Innovative Research, Ghaziabad, 201002, India.
Dasgupta A; Division of Microbiology, CSIR-Central Drug Research Institute, Sector 10, Janakipuram Extension, Sitapur Road, Lucknow, 226031, India.
Rana P; Division of Microbiology, CSIR-Central Drug Research Institute, Sector 10, Janakipuram Extension, Sitapur Road, Lucknow, 226031, India.
Srinivas N; Academy of Scientific & Innovative Research, Ghaziabad, 201002, India.
Chopra S; Department of Process & Medicinal Chemistry, National Institute of Pharmaceutical Education & Research, NH 9, Balanagar Main Rd, Kukatpally Industrial Estate, Balanagar, Hyderabad, Telangana, 500037. India.

Future Med Chem ; 14(15): 1133-1148, 2022 08.

Article em En | MEDLINE | ID: mdl-35861021

Assuntos

Anti-Infecciosos; Infecções Bacterianas; Antibacterianos/farmacologia; Antibacterianos/uso terapêutico; Anti-Infecciosos/uso terapêutico; Infecções Bacterianas/tratamento farmacológico; Farmacorresistência Bacteriana Múltipla; Humanos

Palavras-chave

AMR; MDR; MRSA; VRE; antibacterial activity; bacteriophage therapy; drug discovery; host-directed therapy; immunomodulation; natural products; novel antimicrobials; resistance mechanisms

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Bacterianas / Anti-Infecciosos Limite: Humans Idioma: En Revista: Future Med Chem Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google